TrialReach raised $13.5 million in a Series B round to scale up its clinical trial discovery platform. The system is designed to accelerate enrollment into clinical research by matching patients to appropriate trials. London-based TrialReach takes a multipronged approach to the task, the first step of which is to convert jargon-heavy trial protocols into layman's terms. Smedvig Capital led the round. Release | More